- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional, Single centre
- Study aim: To assess clinical improvement in patients with chronic fatigue syndrome and post-acute COVID-19 syndrome three months after the completion of immunoadsorption
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 6 months
Study Data
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to